Search Within
554-95-0
Applied Filters:
Keyword:'554-95-0'
Showing 1-4 of 4 results for "554-95-0" within Papers
Fabio A B Schutz et al.
The Lancet. Oncology, 14(1), 81-87 (2012-12-12)
Germline genetic polymorphisms might affect the risk of recurrence in patients with localised renal-cell carcinoma. We investigated the association between genetic polymorphisms and recurrence of renal-cell carcinoma. We analysed germline DNA samples extracted from patients with localised renal-cell carcinoma treated
Angelo Di Leo et al.
Journal of the National Cancer Institute, 106(1), djt337-djt337 (2013-12-10)
At the time of the initial analysis of overall survival (OS) for the Comparison of Faslodex in Recurrent or Metastatic Breast Cancer (CONFIRM) randomized, double-blind, phase III trial, approximately 50% of patients had died. A final analysis of OS was
Thomas D Giles et al.
Lancet (London, England), 383(9932), 1889-1898 (2014-06-03)
The fixed-dose combination of any two antihypertensive drugs from different drug classes is typically more effective in reducing blood pressure than a dose increase of component monotherapy. We assessed the efficacy and safety of a fixed-dose combination of a vasodilating
Morris Gordon et al.
The Cochrane database of systematic reviews, 1, CD013529-CD013529 (2021-01-21)
Inflammatory bowel disease affects approximately seven million people globally. Iron deficiency anaemia can occur as a common systemic manifestation, with a prevalence of up to 90%, which can significantly affect quality of life, both during periods of active disease or
Page 1 of 1